Hans Mallmin
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Denosumab and bone loss in uncemented total hip arthroplasty: a secondary 5-year follow-up of a randomized controlled trial.
Journal: Acta orthopaedica
Published: August 06, 2025
Uncemented hip arthroplasty and denosumab: increased postoperative dipeptide concentrations and identification of potential new bone turnover biomarkers.
Journal: JBMR plus
Published: November 27, 2024
Continuous periprosthetic bone loss around the TOP® cup and inferior survival rate at an 8-year follow-up: a prospective cohort study.
Journal: BMC musculoskeletal disorders
Published: November 01, 2023
Sarcopenia prevalence and incidence in older men - a MrOs Sweden study.
Journal: Geriatric nursing (New York, N.Y.)
Published: October 17, 2022
Denosumab prevents acetabular bone loss around an uncemented cup: analysis of secondary outcomes in a randomized controlled trial.
Journal: Acta orthopaedica
Published: March 15, 2022
Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty-results from a randomized placebo-controlled clinical trial.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: January 18, 2022
Continuous periprosthetic bone loss but preserved stability for a collum femoris-preserving stem: follow-up of a prospective cohort study of 21 patients with dualenergy X-ray absorptiometry and radiostereometric analysis with minimum 8 years of follow-up.
Journal: Acta orthopaedica
Published: April 29, 2021
Reply to Denosumab in Prevention of Implant Migration.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: May 14, 2020
In Reply to the Letter to the Editor: The Efficacy of Denosumab for Prevention of Early Periprosthetic Bone Loss After Cementless Total Hip Arthroplasty.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: January 09, 2020
Safety of Use of Tantalum in Total Hip Arthroplasty.
Journal: The Journal of bone and joint surgery. American volume
Published: January 03, 2020
Denosumab Prevents Early Periprosthetic Bone Loss After Uncemented Total Hip Arthroplasty: Results from a Randomized Placebo-Controlled Clinical Trial.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: January 20, 2019
Haplotypes in the CYP2R1 gene are associated with levels of 25(OH)D and bone mineral density, but not with other markers of bone metabolism (MrOS Sweden).
Journal: PloS one
Published: May 26, 2018
Last Updated: 09/26/2026